Ketodapt-DS Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement primarily used in the management of chronic kidney disease (CKD). It serves as a precursor to essential amino acids, helping to reduce the accumulation of nitrogenous waste products in patients with impaired renal function. By providing ketoanalogues of essential amino acids, Ketodapt-DS supports protein synthesis while minimizing nitrogen load, thereby aiding in the delay of progression of renal failure and reducing uremic symptoms. This medication is often prescribed alongside a low-protein diet to optimize metabolic balance and improve patient outcomes. The tablet is indicated for patients with moderate to severe CKD who require nutritional support without exacerbating azotemia. Ketodapt-DS should be administered under medical supervision, with dosage adjusted according to the patient’s renal status and dietary protein intake. It is contraindicated in patients with hypersensitivity to any component of the formulation. Common precautions include monitoring of serum electrolytes, renal function tests, and nutritional status during therapy. Adverse effects are generally rare but may include gastrointestinal disturbances or allergic reactions. Ketodapt-DS Tablet represents a valuable adjunct in the comprehensive management of CKD, aiming to preserve residual kidney function and improve quality of life.